Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

Government ‘joins-up’ system

May 15, 2013
Sales and Marketing NHS, NICE, government, king's fund

The government has launched its plans to create ‘a truly joined-up system’ for the provision of health and social care …

News
NICE image

NICE to assess drug value

March 22, 2013
Sales and Marketing EMIG, NHS, NICE, VBP

NICE will be responsible for assessing the full value of medicines – taking into account their benefit to patients and …

News
Eliquis image

Eliquis approved by NICE

February 28, 2013
Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

News
NICE image

NICE rejects Jakavi

February 13, 2013
Sales and Marketing Jakavi, NICE

NICE has today issued draft guidance saying it does not recommend Novartis’ Jakavi for patients with myelofibrosis, a rare blood …

News
Forxiga image

NICE rejects Forxiga

February 1, 2013
Sales and Marketing AstraZeneca, BMS, Forxiga, NICE, diabetes

NICE has given the thumbs-down to AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga. The drug was approved …

News
NICE image

NICE hits back at ‘limited’ EC study

January 28, 2013
Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead

NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …

News

MPs: ‘get on with VBP’

January 18, 2013
Medical Communications, Sales and Marketing NHS, NICE, PPRS, VBP

An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …

News
NICE image

The price of innovation

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, NICE, Rose, VBP

One of the strange paradoxes of our industry is that we have a very large number of new medicines in …

Feature
Tamoxifen image

NICE consults on tamoxifen

January 15, 2013
Sales and Marketing Cancer, Evista, NICE, lilly, tamoxifen

Patient groups have welcomed NICE’s new draft guideline recommending the use of preventive treatments in women who have a family …

News
lucentis

New price and data changes NICE view on Lucentis

January 4, 2013
Sales and Marketing Bayer, Eylea, Lucentis, NICE, Novartis

A new lower price and new data analysis has persuaded NICE to recommend Lucentis for patients with diabetic macular oedema …

News

NICE publishes formulary guidance

December 19, 2012
Sales and Marketing ABPI, NHS, NICE, formularies, formulary

NICE has published its first guidance on good practice for those involved in working out what medicines should be made …

News
haslam

David Haslam confirmed as NICE chair

December 18, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Haslam, Hunt, NICE

David Haslam has been confirmed as chair of the National Institute for Health and Clinical Excellence. Professor Haslam is currently …

Appointment

‘Open door’ for pharma

December 6, 2012
Sales and Marketing CCGs, NHS, NICE, Pharmafocus, Prescriber, UK

The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …

News
NICE image

NICE: ‘lot of work’ to do on VBP

November 30, 2012
Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP

NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …

News
ABPI image

‘Adopt NICE decisions’ committee told

November 27, 2012
Sales and Marketing ABPI, Dorrell, NHS, NICE, Whitehead

ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026